-
Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice.
Hum Gene Ther. 2003 May 20;14(8):777-87
PMID: 12804140
-
Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.
Hum Gene Ther. 2005 Jun;16(6):664-77
PMID: 15960598
-
Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.
Hum Gene Ther. 2003 Nov 20;14(17):1595-604
PMID: 14633402
-
A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells.
Hum Gene Ther. 2003 Nov 20;14(17):1631-41
PMID: 14633405
-
Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.
J Virol. 2003 Dec;77(24):13062-72
PMID: 14645563
-
Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
J Virol. 2004 Mar;78(5):2572-80
PMID: 14963160
-
Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway.
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6200-5
PMID: 15071185
-
Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells.
J Virol. 2004 Aug;78(15):8047-58
PMID: 15254176
-
Immune responses to gene therapy vectors: influence on vector function and effector mechanisms.
Gene Ther. 2004 Oct;11 Suppl 1:S10-7
PMID: 15454952
-
Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.
Cell. 1993 Apr 23;73(2):309-19
PMID: 8477447
-
Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery.
J Virol. 1995 Apr;69(4):2257-63
PMID: 7533853
-
Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.
J Immunol. 1995 Sep 1;155(5):2564-70
PMID: 7650386
-
Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
Eur J Immunol. 1995 Dec;25(12):3467-73
PMID: 8566039
-
Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.
J Virol. 1996 Apr;70(4):2116-23
PMID: 8642632
-
Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells.
J Virol. 1996 Jul;70(7):4502-8
PMID: 8676475
-
Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.
Hum Gene Ther. 1997 Jan 1;8(1):37-44
PMID: 8989993
-
Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.
Science. 1997 Feb 28;275(5304):1320-3
PMID: 9036860
-
HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3352-6
PMID: 9096397
-
Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells.
EMBO J. 1997 May 1;16(9):2294-306
PMID: 9171344
-
The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.
J Virol. 1997 Nov;71(11):8798-807
PMID: 9343240
-
The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F.
J Virol. 1998 Oct;72(10):7909-15
PMID: 9733828
-
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.
J Virol. 1998 Dec;72(12):9706-13
PMID: 9811704
-
Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.
Am J Respir Cell Mol Biol. 1999 Mar;20(3):361-70
PMID: 10030833
-
RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection.
J Virol. 1999 Jun;73(6):5156-61
PMID: 10233980
-
Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density.
J Virol. 1999 Aug;73(8):7077-9
PMID: 10400813
-
Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
J Virol. 2005 Sep;79(18):11627-37
PMID: 16140740
-
Akt/protein kinase B activation by adenovirus vectors contributes to NFkappaB-dependent CXCL10 expression.
J Virol. 2005 Dec;79(23):14507-15
PMID: 16282450
-
Rapid Kupffer cell death after intravenous injection of adenovirus vectors.
Mol Ther. 2006 Jan;13(1):108-17
PMID: 16198149
-
Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity.
Hum Gene Ther. 2006 Mar;17(3):264-79
PMID: 16544976
-
Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR.
Science. 1999 Nov 19;286(5444):1579-83
PMID: 10567268
-
Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells.
J Virol. 2000 Jan;74(1):354-62
PMID: 10590124
-
Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.
Mol Ther. 2001 May;3(5 Pt 1):697-707
PMID: 11356075
-
Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.
J Virol. 2001 Sep;75(18):8772-80
PMID: 11507222
-
CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors.
Gene Ther. 2001 Sep;8(17):1347-53
PMID: 11571572
-
In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.
Mol Ther. 2002 Jun;5(6):770-9
PMID: 12027562
-
Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.
J Virol. 2003 Jan;77(2):1039-48
PMID: 12502819
-
Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.
J Virol. 2003 Feb;77(4):2512-21
PMID: 12551989
-
The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors.
Hum Gene Ther. 2003 May 1;14(7):627-43
PMID: 12804145
-
Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.
Gene Ther. 1999 Sep;6(9):1520-35
PMID: 10490761
-
The innate immune response to adenovirus vectors.
Hum Gene Ther. 2004 Dec;15(12):1157-66
PMID: 15684693
-
Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice.
Gene Ther. 2005 Mar;12(5):427-36
PMID: 15647774
-
Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity.
J Virol. 2005 Jun;79(12):7478-91
PMID: 15919903
-
Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism.
Mol Ther. 2003 Sep;8(3):485-94
PMID: 12946322